Artelo Biosciences, Inc. ARTL

Full chart Compare
Set alert

Price alert · ARTL

All alert types
2.27 USD -0.13 (-5.42%)

At closeNov 4, 2026, 4:00 PM EST

2.27 0.00 0.00%

After hours · Nov 4, 4:00 PM ET

2.20 Day range 2.42
2.05 52-week range 179.19
YTD
-93.11%
1 year
-95.48%

Financial health

Altman Z-Score

-17.09 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 5

Valuation

P/E -0.2×
FY 2015: -2672×FY 2016: -389×FY 2017: -45.6×FY 2018: -35.1×FY 2019: -13.8×FY 2020: -41.2×FY 2022: -14.9×FY 2023: -8.0×FY 2024: -6.3×FY 2025: -0.2×
FY 2015 5y median -8.0× FY 2025
P/S 0.0×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2015 5y median 0.0× FY 2025
P/B -2.3×
FY 2015: -955×FY 2016: 27.7×FY 2017: -130×FY 2018: 2.3×FY 2019: 2.8×FY 2020: 4.2×FY 2022: 1.3×FY 2023: 6.3×FY 2024: 21.5×FY 2025: -2.3×
FY 2015 5y median 4.2× FY 2025
P/FCF -0.3×
FY 2015: -713×FY 2016: -69.5×FY 2017: -10.9×FY 2018: -2.9×FY 2019: -2.5×FY 2020: -8.3×FY 2022: -3.1×FY 2023: -9.1×FY 2024: -7.4×FY 2025: -0.3×
FY 2015 5y median -7.4× FY 2025
EV/EBITDA -0.2×
FY 2015: 444×FY 2016: -62.3×FY 2017: -7.4×FY 2018: -1.9×FY 2019: -1.8×FY 2020: -6.0×FY 2022: -1.8×FY 2023: -7.7×FY 2024: -6.0×FY 2025: -0.2×
FY 2015 5y median -6.0× FY 2025
EV/Sales 0.0×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2015 5y median 0.0× FY 2025
FCF Yield -296.4%
FY 2015: -0.1%FY 2016: -1.4%FY 2017: -9.2%FY 2018: -34.0%FY 2019: -40.7%FY 2020: -12.0%FY 2022: -32.6%FY 2023: -11.0%FY 2024: -13.6%FY 2025: -296.4%
FY 2015 5y median -13.6% FY 2025

Profitability

Gross Margin 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
ROE 1012.5%
FY 2015: 215.1%FY 2016: -43.1%FY 2017: 1736.3%FY 2018: -39.8%FY 2019: -120.1%FY 2020: -61.8%FY 2022: -52.0%FY 2023: -79.0%FY 2024: -343.9%FY 2025: 1012.5%
FY 2015 5y median -61.8% FY 2025
ROIC 1919.9%
FY 2015: 215.1%FY 2016: -42.7%FY 2017: 1736.3%FY 2018: -3.5%FY 2019: -120.9%FY 2020: -61.3%FY 2022: -52.8%FY 2023: -84.3%FY 2024: -341.4%FY 2025: 1919.9%
FY 2015 5y median -61.3% FY 2025
ROA -459.8%
FY 2015: -827.0%FY 2016: -40.9%FY 2017: -590.3%FY 2018: -33.5%FY 2019: -106.4%FY 2020: -58.9%FY 2022: -49.4%FY 2023: -71.2%FY 2024: -209.2%FY 2025: -459.8%
FY 2015 5y median -71.2% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 FY 2025
Operating Income -12.8%
FY 2015: -94.8%FY 2016: -684.1%FY 2017: -906.7%FY 2018: -37.0%FY 2019: -46.0%FY 2020: -58.8%FY 2022: 0.0%FY 2023: 3.5%FY 2024: -1.8%FY 2025: -12.8%
FY 2015 FY 2025
EPS (diluted) -438.1%
FY 2015: -95.8%FY 2016: -587.2%FY 2017: -752.0%FY 2018: 45.5%FY 2019: -25.5%FY 2020: 68.3%FY 2022: 0.0%FY 2023: 10.0%FY 2024: 2.9%FY 2025: -438.1%
FY 2015 FY 2025
Free Cash Flow -2.0%
FY 2015: -36.9%FY 2016: -1072.7%FY 2017: -642.9%FY 2018: -166.5%FY 2019: -1.2%FY 2020: -41.3%FY 2022: 0.0%FY 2023: -2.5%FY 2024: -1.7%FY 2025: -2.0%
FY 2015 FY 2025

Financial Health

Current Ratio 0.2×
FY 2015: 0.2×FY 2016: 19.5×FY 2017: 0.7×FY 2018: 4.3×FY 2019: 4.7×FY 2020: 19.6×FY 2022: 18.4×FY 2023: 8.5×FY 2024: 1.4×FY 2025: 0.2×
FY 2015 5y median 8.5× FY 2025
Quick Ratio 0.2×
FY 2015: 0.2×FY 2016: 19.5×FY 2017: 0.7×FY 2018: 4.4×FY 2019: 4.7×FY 2020: 19.6×FY 2022: 18.4×FY 2023: 8.5×FY 2024: 1.4×FY 2025: 0.2×
FY 2015 5y median 8.5× FY 2025
Debt / Equity -0.5×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -0.5×
FY 2015 5y median 0.0× FY 2025
Net Debt / EBITDA -0.0×
FY 2015: -0.1×FY 2016: 2.5×FY 2017: 0.1×FY 2018: 1.0×FY 2019: 0.5×FY 2020: 0.9×FY 2022: 0.7×FY 2023: 0.3×FY 2024: 0.2×FY 2025: -0.0×
FY 2015 5y median 0.3× FY 2025
Interest Coverage -58.8×
FY 2015: 0.0×FY 2016: -111×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2022: -2057×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -58.8×
FY 2015 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2015 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31